Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)
All News about Corcept Therapeutics Incorporated - Common Stock
Corcept Completes Enrollment in Phase 4 CATALYST Trial
April 29, 2024
Via GlobeNewswire
Corcept Appoints Roberto Vieira as President, Oncology
January 29, 2024
Via GlobeNewswire